$NKLA
Nikola Corp

2024 Q2 Form 10-Q Financial Statement

#000173128924000155 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $31.32M $7.497M $11.12M
YoY Change 103.87% -32.56% 489.14%
Cost Of Revenue $86.05M $65.07M $44.03M
YoY Change 100.14% 47.8% 2923.83%
Gross Profit -$54.73M -$57.58M -$32.91M
YoY Change 98.06% 74.95% -7735.73%
Gross Profit Margin -174.74% -767.97% -296.03%
Selling, General & Admin $36.24M $48.29M $53.71M
YoY Change -38.33% -10.09% -30.41%
% of Gross Profit
Research & Development $40.16M $39.50M $64.43M
YoY Change -37.75% -38.69% -13.59%
% of Gross Profit
Depreciation & Amortization $9.300M $10.60M $7.052M
YoY Change 97.45% 50.26% 126.68%
% of Gross Profit
Operating Expenses $76.40M $87.79M $118.1M
YoY Change -45.82% -25.69% -22.15%
Operating Profit -$131.1M -$145.4M -$151.0M
YoY Change -22.24% -3.76% -0.17%
Interest Expense -$3.941M -$2.278M -$9.863M
YoY Change -54.95% -76.9% 4574.41%
% of Operating Profit
Other Income/Expense, Net $3.893M $860.0K -$84.00K
YoY Change -170.19% -1123.81% -104.58%
Pretax Income -$132.7M -$147.6M -$160.7M
YoY Change 0.23% -8.17% 7.04%
Income Tax $92.00K $0.00 $0.00
% Of Pretax Income
Net Earnings -$133.7M -$147.7M -$169.1M
YoY Change -38.63% -12.64% 10.56%
Net Earnings / Revenue -426.81% -1970.41% -1521.04%
Basic Earnings Per Share -$2.86 -$0.11 -$0.31
Diluted Earnings Per Share -$2.86 -$0.11 -$0.31
COMMON SHARES
Basic Shares Outstanding 1.357B shares 1.336B shares 554.4M shares
Diluted Shares Outstanding 46.70M shares 1.336B shares 549.7M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $256.3M $345.6M $121.1M
YoY Change 13.08% 185.32% -66.36%
Cash & Equivalents $256.3M $345.6M $121.1M
Short-Term Investments
Other Short-Term Assets $816.0K $28.67M $14.36M
YoY Change -98.18% 99.68% -54.76%
Inventory $62.13M $61.34M $123.6M
Prepaid Expenses
Receivables $39.84M $23.87M $27.58M
Other Receivables $6.845M $9.799M $17.95M
Total Short-Term Assets $430.1M $469.3M $330.8M
YoY Change 10.72% 41.88% -21.06%
LONG-TERM ASSETS
Property, Plant & Equipment $494.0M $484.5M $475.4M
YoY Change 2.27% 1.91% 79.99%
Goodwill $5.238M $5.238M $6.688M
YoY Change 0.0% -21.68% 27.68%
Intangibles $82.16M $84.01M $91.92M
YoY Change -8.27% -8.61% -5.41%
Long-Term Investments $56.02M $56.91M $68.68M
YoY Change -3.89% -17.14% 9.65%
Other Assets $17.39M $11.81M $33.10M
YoY Change -74.68% -64.33% 887.15%
Total Long-Term Assets $679.8M $682.8M $827.6M
YoY Change -9.24% -17.49% 68.44%
TOTAL ASSETS
Total Short-Term Assets $430.1M $469.3M $330.8M
Total Long-Term Assets $679.8M $682.8M $827.6M
Total Assets $1.110B $1.152B $1.158B
YoY Change -2.43% -0.54% 27.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.56M $44.91M $78.02M
YoY Change 21.4% -42.44% 0.7%
Accrued Expenses $214.0M $212.1M $204.2M
YoY Change 19.52% 3.86% 88.76%
Deferred Revenue
YoY Change
Short-Term Debt $4.598M $0.00 $0.00
YoY Change 30.33%
Long-Term Debt Due $7.208M $6.233M $21.76M
YoY Change -27.11% -71.36% 4191.91%
Total Short-Term Liabilities $281.3M $271.3M $276.5M
YoY Change 18.11% -1.9% 50.58%
LONG-TERM LIABILITIES
Long-Term Debt $266.4M $268.3M $296.5M
YoY Change -23.54% -9.49% 1083.76%
Other Long-Term Liabilities $31.26M $20.97M $7.697M
YoY Change 11.0% 172.5% -89.34%
Total Long-Term Liabilities $31.26M $20.97M $7.697M
YoY Change -91.7% 172.5% -89.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $281.3M $271.3M $276.5M
Total Long-Term Liabilities $31.26M $20.97M $7.697M
Total Liabilities $586.4M $565.9M $612.5M
YoY Change -4.62% -7.61% 112.53%
SHAREHOLDERS EQUITY
Retained Earnings -$3.352B -$3.219B -$2.204B
YoY Change 38.43% 46.05% 57.03%
Common Stock $5.000K $134.0K $59.00K
YoY Change -93.51% 127.12% 40.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $523.6M $586.3M $545.9M
YoY Change
Total Liabilities & Shareholders Equity $1.110B $1.152B $1.158B
YoY Change -2.43% -0.54% 27.24%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$133.7M -$147.7M -$169.1M
YoY Change -38.63% -12.64% 10.56%
Depreciation, Depletion And Amortization $9.300M $10.60M $7.052M
YoY Change 97.45% 50.26% 126.68%
Cash From Operating Activities -$134.6M -$115.6M -$180.0M
YoY Change 25.51% -35.76% 37.04%
INVESTING ACTIVITIES
Capital Expenditures $13.72M $16.46M $52.29M
YoY Change -61.26% -68.52% -273.68%
Acquisitions
YoY Change
Other Investing Activities $0.00 $21.40M $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$13.72M $4.940M -$52.29M
YoY Change 323.84% -109.45% 56.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 52.65M -$5.055M $115.6M
YoY Change -74.75% -104.37% 318.05%
NET CHANGE
Cash From Operating Activities -134.6M -$115.6M -$180.0M
Cash From Investing Activities -13.72M $4.940M -$52.29M
Cash From Financing Activities 52.65M -$5.055M $115.6M
Net Change In Cash -95.63M -$115.7M -$116.6M
YoY Change -197.5% -0.79% -14.94%
FREE CASH FLOW
Cash From Operating Activities -$134.6M -$115.6M -$180.0M
Capital Expenditures $13.72M $16.46M $52.29M
Free Cash Flow -$148.3M -$132.1M -$232.3M
YoY Change 3.96% -43.14% 129.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-169094000 usd
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1342842964 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1342842964 shares
CY2024Q1 nkla Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns
RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturns
7497000 usd
CY2023Q1 nkla Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns
RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturns
10677000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
65072000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33374000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
-57575000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
-22697000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39497000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61806000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48291000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42697000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
87788000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
104503000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-145363000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-127200000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2278000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9833000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-784000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
860000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
190000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-147565000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-136843000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 nkla Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax
-147565000 usd
CY2023Q1 nkla Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax
-136843000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-157000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8408000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-147722000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-145251000 usd
CY2024Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
0 usd
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-23843000 usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-23843000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-147722000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-169094000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.11
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.11
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.26
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.26
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.05
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.05
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1335877351 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1335877351 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
549689436 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
549689436 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-147722000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-169094000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
120000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-53000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-147602000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-169147000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
719174000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
8786000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-147722000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
120000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
586275000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
526479000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
166000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
24548000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-53000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
545871000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-147722000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-169094000 usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-23843000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-147722000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-145251000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10596000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6238000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
8786000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
24487000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-157000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8408000 usd
CY2024Q1 nkla Fair Value Adjustment Of Warrants And Derivative Gain Loss On Derivative Net
FairValueAdjustmentOfWarrantsAndDerivativeGainLossOnDerivativeNet
-826000 usd
CY2023Q1 nkla Fair Value Adjustment Of Warrants And Derivative Gain Loss On Derivative Net
FairValueAdjustmentOfWarrantsAndDerivativeGainLossOnDerivativeNet
199000 usd
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
20044000 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
2275000 usd
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
3625000 usd
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
10008000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-2688000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
0 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2871000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-486000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5892000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4299000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17788000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5905000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
10297000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
39711000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
389000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1929000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11819000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-40092000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-763000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-414000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
5836000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1278000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-115603000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-176022000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16458000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50517000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
21398000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4940000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50517000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
404000 usd
CY2024Q1 nkla Proceeds From Issuance Of Common Stock Net Of Commissions Paid
ProceedsFromIssuanceOfCommonStockNetOfCommissionsPaid
0 usd
CY2023Q1 nkla Proceeds From Issuance Of Common Stock Net Of Commissions Paid
ProceedsFromIssuanceOfCommonStockNetOfCommissionsPaid
30524000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
25000000 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
130000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2544000 usd
CY2024Q1 nkla Payment For Coupon Make Whole Premiums
PaymentForCouponMakeWholePremiums
1747000 usd
CY2023Q1 nkla Payment For Coupon Make Whole Premiums
PaymentForCouponMakeWholePremiums
0 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1853000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1999000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1276000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
182000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
49000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5055000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
115916000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-115718000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-110623000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
493965000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
313909000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
378247000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
203286000 usd
CY2024Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
CY2023Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-3939000 usd
CY2024Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 usd
CY2023Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-1772000 usd
CY2024Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 usd
CY2023Q1 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-308000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-6019000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
2896000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1490000 usd
CY2024Q1 nkla Interest Received
InterestReceived
5330000 usd
CY2023Q1 nkla Interest Received
InterestReceived
1583000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
12039000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
26827000 usd
CY2024Q1 nkla Accrued Paid In Kind Interest
AccruedPaidInKindInterest
3625000 usd
CY2023Q1 nkla Accrued Paid In Kind Interest
AccruedPaidInKindInterest
5801000 usd
CY2024Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
89000 usd
CY2023Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
550000 usd
CY2024Q1 nkla Accrued Underwriting Commissions
AccruedUnderwritingCommissions
0 usd
CY2023Q1 nkla Accrued Underwriting Commissions
AccruedUnderwritingCommissions
593000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
345600000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
464700000 usd
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
33400000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
29800000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
32600000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
29300000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
345637000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
464715000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119604000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1224000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1224000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10600000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
31386000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
28026000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
73082000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
378247000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
493965000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
203286000 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
8027000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
8871000 usd
CY2024Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
8600000 usd
CY2023Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
700000 usd
CY2024Q1 nkla Standard Product Warranty Accrual Increase For Recalls Issued
StandardProductWarrantyAccrualIncreaseForRecallsIssued
65000000 usd
CY2024Q1 nkla Standard Product Warranty Accrual Decrease For Recall Payments
StandardProductWarrantyAccrualDecreaseForRecallPayments
9700000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
78946000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
7788000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
9664000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1793000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-1293000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-302000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
6648000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
31000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
80669000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
9248000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
61500000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
19200000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
65700000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
13200000 usd
CY2024Q1 nkla Prepaid Software Current
PrepaidSoftwareCurrent
2815000 usd
CY2023Q4 nkla Prepaid Software Current
PrepaidSoftwareCurrent
1421000 usd
CY2024Q1 nkla Sale Agreement Receivable Current
SaleAgreementReceivableCurrent
1653000 usd
CY2023Q4 nkla Sale Agreement Receivable Current
SaleAgreementReceivableCurrent
675000 usd
CY2024Q1 us-gaap Prepaid Insurance
PrepaidInsurance
1606000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2148000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
479000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
479000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37241000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25911000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
29782000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
32889000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
16591000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
15486000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8919000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8206000 usd
CY2024Q1 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
6050000 usd
CY2023Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
6007000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
61342000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
62588000 usd
CY2024Q1 nkla Inventory Deposits Current
InventoryDepositsCurrent
11308000 usd
CY2023Q4 nkla Inventory Deposits Current
InventoryDepositsCurrent
4843000 usd
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
5505000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
6152000 usd
CY2024Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
4913000 usd
CY2023Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
4895000 usd
CY2024Q1 nkla Holdback Receivable
HoldbackReceivable
4886000 usd
CY2023Q4 nkla Holdback Receivable
HoldbackReceivable
3655000 usd
CY2024Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4076000 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1643000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
37109000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
37504000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
536849000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
547365000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
52378000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
43949000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
484471000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
503416000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
8600000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
4200000 usd
CY2024Q1 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
87063000 usd
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
91330000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
61467000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
65703000 usd
CY2024Q1 nkla Accrued Purchase Of Intangible Asset
AccruedPurchaseOfIntangibleAsset
18885000 usd
CY2023Q4 nkla Accrued Purchase Of Intangible Asset
AccruedPurchaseOfIntangibleAsset
13796000 usd
CY2024Q1 nkla Goods Received Not Yet Invoiced
GoodsReceivedNotYetInvoiced
15233000 usd
CY2023Q4 nkla Goods Received Not Yet Invoiced
GoodsReceivedNotYetInvoiced
8642000 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8027000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8871000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8922000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5186000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7691000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3254000 usd
CY2024Q1 nkla Accrued Outsourced Engineering Services Current
AccruedOutsourcedEngineeringServicesCurrent
6363000 usd
CY2023Q4 nkla Accrued Outsourced Engineering Services Current
AccruedOutsourcedEngineeringServicesCurrent
4207000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2418000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1867000 usd
CY2024Q1 nkla Accrued Purchases Of Property And Equipment Current
AccruedPurchasesOfPropertyAndEquipmentCurrent
2317000 usd
CY2023Q4 nkla Accrued Purchases Of Property And Equipment Current
AccruedPurchasesOfPropertyAndEquipmentCurrent
2458000 usd
CY2024Q1 nkla Accrued Legal Liabilities Current
AccruedLegalLiabilitiesCurrent
1765000 usd
CY2024Q1 nkla Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
220151000 usd
CY2023Q4 nkla Accrued Legal Liabilities Current
AccruedLegalLiabilitiesCurrent
1708000 usd
CY2023Q4 nkla Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
207022000 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
98831000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14821000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
84010000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
98831000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12971000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
85860000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
56905000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
57062000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-157000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8408000 usd
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
5325000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
6312000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
6233000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
8950000 usd
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
25916000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
26395000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
268345000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
269279000 usd
CY2024Q1 nkla Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
1750000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1600000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
150000000 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021Q2 nkla Sale Of Stock Purchase Period
SaleOfStockPurchasePeriod
P36M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15041373 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.37
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y7M20D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
8493 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.28
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15032880 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y4M17D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
15032880 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.37
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y4M17D
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8786000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24548000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
37886000 usd
CY2020Q3 nkla Number Of Derivative Actions
NumberOfDerivativeActions
2 derivative_action
CY2020Q4 nkla Period Of Derivative Action
PeriodOfDerivativeAction
P30D
CY2021Q1 nkla Period Of Derivative Action
PeriodOfDerivativeAction
P30D
CY2023Q1 nkla Inventory Repurchase Term
InventoryRepurchaseTerm
P15M
CY2024Q1 nkla Inventory Repurchase Maximum Potential
InventoryRepurchaseMaximumPotential
13700000 usd
CY2024Q1 nkla Standard Product Warranty Accrual Increase For Recalls Issued
StandardProductWarrantyAccrualIncreaseForRecallsIssued
65000000 usd
CY2023 nkla Standard Product Warranty Accrual Increase For Recalls Issued
StandardProductWarrantyAccrualIncreaseForRecallsIssued
65800000 usd
CY2024Q1 nkla Standard Product Warranty Accrual Decrease For Recall Payments
StandardProductWarrantyAccrualDecreaseForRecallPayments
9700000 usd
CY2023 nkla Standard Product Warranty Accrual Decrease For Recall Payments
StandardProductWarrantyAccrualDecreaseForRecallPayments
3000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-147722000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-145251000 usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-23843000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-147722000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-169094000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1335877351 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1335877351 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
549689436 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
549689436 shares
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.11
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.11
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.26
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.26
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.05
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.05
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
77163139 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
83501459 shares
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001731289-24-000155-index-headers.html Edgar Link pending
0001731289-24-000155-index.html Edgar Link pending
0001731289-24-000155.txt Edgar Link pending
0001731289-24-000155-xbrl.zip Edgar Link pending
exhibit311q12024.htm Edgar Link pending
exhibit312q12024.htm Edgar Link pending
exhibit321q12024.htm Edgar Link pending
exhibit322q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nikola-ex103xnelasatermina.htm Edgar Link pending
nkla-20240331.htm Edgar Link pending
nkla-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
nkla-20240331_cal.xml Edgar Link unprocessable
nkla-20240331_def.xml Edgar Link unprocessable
nkla-20240331_lab.xml Edgar Link unprocessable
nkla-20240331_pre.xml Edgar Link unprocessable
nkla-20240331_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable